期刊文献+

CD147蛋白在前列腺癌中的表达及临床意义 被引量:6

Expression and Clinical Significance of CD 147 Protein in Human Prostate Cancer
下载PDF
导出
摘要 【目的】研究前列腺癌及前列腺增生组织中CD147蛋白的表达及其临床意义。【方法】采用免疫组化S‐P法检测56例前列腺癌组织及22例前列腺增生组织中CD147蛋白的表达情况,分析其与前列腺癌临床生物学特性的相关性。【结果】观察组CD147蛋白阳性率为643.%显著高于对照组的91.%,差异具有统计学意义( P <00.1)。不同年龄段患者CD147蛋白的阳性表达无显著性差异( P >00.5),不同 T N M 分期及病理分级 Gleason评分CD147蛋白的阳性表达有显著性差异( P <00.5),各级别组CD147蛋白阳性表达率差异有统计学意义( P <00.5)。【结论】前列腺癌组织中CD147高表达,并与其病理分期及临床分期有关。CD147有可能成为判断前列腺癌侵袭力的重要指标,阻断CD147的表达可能成为治疗前列腺肿瘤的新靶点。 Objective]To investigate the expression and clinical significance of CD147 protein in human prostate cancer and benign prostatic hyperplasia tissues .[Methods]The immunohistochemical S‐P method was used to detect the expression of CD147 protein in 56 patients of prostate cancer tissues and 22 patients of be‐nign prostatic hyperplasia tissues so as To analyze the correlation between CD 147 protein and the clinical bio‐logical characteristics of prostate cancer .[Results]The positive rate of CD147 protein in the observation group was 9 1.% ,which was significantly higher than that in the control group ,the difference was statistically sig‐nificant ( P 〈0 0.1) .There was no significant difference in CD147 protein expression in different age groups ( P 〉0 0.5) .The positive expression of CD147 protein in different stages of Gleason staging and pathological grading was significantly different ( P 〈0 0.5) ,The positive expression rate of CD147 protein in each grade group was statistically significant ( P 〈0 0.5) .[Conclusions] The high expression of CD147 in prostate cancer tissues is related to its pathological stage and clinical stage .CD147 has the potential to be an important indica‐tor to judge the invasion of prostate cancer ,and to block the expression of CD147 may become a new target for the treatment of prostate cancer .
出处 《医学临床研究》 CAS 2015年第11期2088-2090,共3页 Journal of Clinical Research
基金 广东省医学科研基金(项目编号B2013433)
关键词 抗原 CD147/生物合成 前列腺肿瘤/病理学 肿瘤侵润 肿瘤分期 Antigens,CD147/BI Prostatic Neoplasms/PA Neoplasm Invasiveness Neoplasm Staging
  • 相关文献

参考文献9

  • 1Bordador LC, Li X, Toole B, et al .Expirssion of emmprin by o- ral sqyamous cell carcinoma[J]. Int J Cancer, 2000,85 (3) : 347-352.
  • 2Marionnet C, Lalou C, Mollier K, et al .Differential molecular profiling between skin carcinomas reveals four newly reported genes potentially implicatett in squamous cell carcinoma devel opment[J]. Oncogene, 2003,22(22) :3500-3505.
  • 3王启林,宋忠于,李瑞乾,赵斌.MVD 、VEGF 在前列腺癌组织中的表达及相关性研究[J].医学临床研究,2014,31(4):701-704. 被引量:1
  • 4矫树华,温艳惠.CD147和MMP-2在胆囊癌组织中的表达及意义[J].医学临床研究,2015,32(4):745-747. 被引量:2
  • 5Sun J, Hemler ME. Regulation of MMP-1 and MMP-2 produc tion through CD147/extracellular matrix metalloproteinase in- ducer interactions [J]. Cancer Res, 2001, 61(5) : 2276- 2281.
  • 6Guo H,Li R, Zucker S, et al . Emmprin (CD147), an inducer o matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface[J]. Cancer Res, 2000, 60 (4) :888-891.
  • 7Borgstrom P, Bourdon MA, Hillan KJ, et al . Neutralizing an- ti-vascular endothelial growth factor antibody completely inhib- its angiogenesis and growth of human prostate carcinoma mi- cro-tumors in vivo [J]. Prostate, 1998, 35(1):1 10.
  • 8陈平锋,李解方.前列腺癌中Survivin与VEGF蛋白表达及其相关性研究[J].中南医学科学杂志,2012,40(5):465-468. 被引量:5
  • 9Tang Y, Nakada M T, Kesavan P, et al .Extracellular matrix metallo proteinase inducer stimulates tumor angiogenesis by el- evating vascular endothelial cell growth factor and matrix met- alloproteinases[J]. Cancer Res, 2005,65(8) 3193-3199.

二级参考文献34

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2周桥.前列腺癌Gleason分级[J].中华病理学杂志,2005,34(4):240-243. 被引量:44
  • 3吴胤瑛,李恩孝.VEGF在恶性肿瘤中的研究进展[J].现代肿瘤医学,2005,13(5). 被引量:56
  • 4阎洪涛,龚百生,董丹丹,杨红,陈照祥.p53和VEGF在前列腺癌组织中的表达及临床意义[J].现代泌尿外科杂志,2007,12(4):242-245. 被引量:9
  • 5马小兵,畅继武.前列腺癌Gleason分级系统的现代观点[J].中华泌尿外科杂志,2007,28(8):573-575. 被引量:1
  • 6Cozzarini C,Fiorino C,Da Pozzo LF. Clinical Factors Predicting Late Severe Urinary Toxicity After Postoperative Radiotherapy for Prostate Carcinoma:A Single-Institute Analysis of 742 Patients[J].International Journal of Radiation Oncology,Biology,Physics,2012,(01):191-199.doi:10.1016/j.ijrobp.2010.09.027.
  • 7Li F,Ambrosini G,Chu EY. Control of apoptosis and mitotic spindle checkpoint by Survivin[J].Nature,1998,(6711):580-584.doi:10.1038/25141.
  • 8Kanwar RK,Cheung CH,Chang JY. Recent advances in anti-Survivin treatments for cancer[J].Current Medicinal Chemistry,2010,(15):1509-1515.doi:10.2174/092986710790979935.
  • 9Sharisat SF,Lotan Y,Saboorian H. Survivin expression is associated with features of biologically aggressive prostate carcinoma[J].Cancer,2004,(04):751-757.
  • 10Ikehara M,Oshita F,Kameda Y. Expression of Survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung[J].Oncology Reports,2002,(04):835-838.

共引文献5

同被引文献93

引证文献6

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部